BUGDF Bumrungrad Hospital PCL featured news, full reports, and detailed charts
Bumrungrad Hospital PCL (BUGDF/BUGDF.PK) Wrap Up:
Bumrungrad Hospital Public Company Limited, together with its subsidiaries, operates hospitals and health care centers primarily in Thailand. It also involves in hospital management business and the rental of properties service. The company is based in Bangkok, Thailand.Bumrungrad Hospital PCL (BUGDF:Pink OTC Markets Inc)
Snapshot of Bumrungrad Hospital PCL (BUGDF)
|
OPEN
--
|
PREVIOUS CLOSE
$0.90
|
|
|
DAY HIGH
--
|
DAY LOW
--
|
|
|
52 WEEK HIGH
10/5/09 - $0.95
|
52 WEEK LOW
09/24/09 - $0.19
|
|
|
MARKET CAP
655.5M
|
AVERAGE VOLUME 3 mo
1.1K
|
|
|
DILUTED EPS TTM
--
|
SHARES OUTSTANDING
728.3M
|
|
|
BUGDF Does Not Pay Dividends
|
P/E TTM
NM
|
|
| K = Thousands M = Millions B = Billions | ||
BUGDF Top Compensated Officers
Executives, Board Directors
Key developments for Bumrungrad Hospital PCL (BUGDF)
Bumrungrad Hospital Public Co. Ltd. provided revenue guidance for the full year of 2010. For the period, the company targets its revenues to increase 10.0%.
Bumrungrad Hospital Public Co. Ltd. reported earnings results for the first half of 2009. For the first half of 2009, net earnings are 47% of full year of 2009.
Bumrungrad Hospital Public Co. Ltd. reported earnings results for the second quarter of 2009. For the quarter, the company reported net profit of THB 288 million, rising 3.1% year on year but dropping 14.7% quarter on quarter. Excluding FX gain, normalized profit was THB 279 million, up 2.2% year on year but down 14.7% quarter on quarter. The year on year improvement was due to an increase in revenue while the quarter on quarter drop was due to seasonality as the second quarter normally is the weak season for hospitals. Revenue was THB 2.2 billion, up 2.4% year on year, but down 3.6% quarter on quarter. The year on year increase was from 2.0% year on year growth in IPD service and 6.0% year on year growth in OPD service. Higher billing per patient on increased complexity in medical treatment was the main reason behind the revenue growth despite patient volume dropping. The quarter on quarter drop was a result of seasonality.
BUGDF Competitors
| Company | Last | Change | |
| No competitor information is available for BUGDF. | |||
| Market data is delayed at least 20 minutes. | |||
Industry Analysis
| Valuation | BUGDF | Industry Range |
| Price/Earnings | 20.1x |
|
| Price/Sales | 2.3x |
|
| Price/Book | 4.0x |
|
| Price/Cash Flow | 11.8x |
|
| TEV/Sales | 2.1x |
|
|
BUGDF |
||
BUGDF transactions
| Type Date |
Target |
|
Private Placement
June 10, 2009 |
Asia Global Research Co., Ltd. |
